Loading
Pharmanutra Pharmanutra Joins the Intermonte Valore Italia Index Stock: price and insider trades · Italy
IT·Mcap €704.7M
Pharmanutra Pharmanutra Joins the Intermonte Valore Italia Index: what insiders have been doing
We have very little insider data for Pharmanutra Pharmanutra Joins the Intermonte Valore Italia Index so far: the most recent filing dates from 2 July 2026. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Consob and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Pharmanutra Pharmanutra Joins the Intermonte Valore Italia Index Strong Buy (bullish), based on 3 analysts. Average price target: €95.67.
Fundamental score
Ranked 6,443 of 24,148 companies
63.2
score / 100
Value41
Quality85
FCF yld2.3%
Earn yld2.8%
EV/EBITDA21.2x
ROE32%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€73.60
Analyst consensus
3 analystsStrong buy
€92.00Target €95.67(+30%)€102.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M14.4% margin
Valuation
PER (trailing)33.9x
PER (forward)23.6x
P/Book10.1x
Beta0.16
Balance sheet & cash
Market cap€704.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE31.6%
ROA16.2%
% insiders65.0%
% institutions16.4%
Last declaration on 2 July 2026
About Pharmanutra Pharmanutra Joins the Intermonte Valore Italia Index
PHARMANUTRA has joined the Intermonte Valore Italia index, strengthening its position in the market. The company is listed on the XMIL market.